江苏科信医药销售有限公司

Jiangsu Hengrui Medicine, founded in 1970, is a biotechnology and pharmaceutical company with a mission to advance quality healthcare solutions for a better life. The company focuses on the development, manufacture, and marketing of diverse medicines and medical packaging materials, including anti-tumor medicines, painkillers, anti-infection medicines, aluminum foil, and related products. Guided by their commitment to improving life through science and technology, Hengrui Medicine is dedicated to researching, developing, and promoting high-quality innovative medicines.

In the context of the healthcare and biotechnology industries, Jiangsu Hengrui Medicine plays a critical role in contributing to global health standards. Their efforts are aimed at assisting doctors in solving clinical problems, aiding patients in recovery, and overall, enhancing healthcare outcomes.

While specific details about the company's headquarters, last investment, and investors are not provided, the company's focus on innovative medicine and commitment to improving healthcare quality positions it as an attractive potential investment opportunity for venture capitalists interested in the biotechnology and pharmaceutical sectors. With an established history and a diverse product range, Jiangsu Hengrui Medicine presents the potential for substantial growth and impact in the healthcare industry.